JW Holdings

JW Group started the holding company system in 2007 to enhance the efficiency and establish responsibility management in the rapidly changing business environment. JW Holdings makes profit mainly from export of medicine and medical supplies as well as equity interest, rental income, brand royalties, service fees from subsidiary companies. We have been cooperated with about 40 global medicine companies such as Chugai, Roche, Abbott, etc., and based on such competitiveness, have been expanding our business scope to raw material,completion medicine and medical supplies, and medical appliance field. We have also completed the construction of infrastructure for penetration of global market such as high-tech manufacturing facility, in accord with the global cGMP standard, in Dangjin, Chungcheongnam-do. Subsidiary companies: JW Pharmaceutical: www.jw-pharma.co.kr/pharma/en/main.jsp JW Shinyak: www.jw-shinyak.co.kr/shinyak/en/main.jsp JW Life Science: www.jw-lifescience.co.kr/lifescience/en/main.jsp JW Medical: www.jw-lifescience.co.kr/lifescience/en/main.jsp JW Industrial: jw-industrial.co.kr/